首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1629829

全球攜帶式製氧機市場 - 2024-2031

Global Portable Oxygen Concentrators Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球攜帶式製氧機市場規模達到20.9億美元，預計2031年將達到50.6億美元，2024-2031年預測期間複合年成長率為11.8%。

攜帶式製氧機 (POC) 是一種緊湊、輕巧的設備，可為外出時有呼吸需求的個人提供補充氧氣。這些機器吸入周圍空氣，對其進行過濾，並透過鼻插管或面罩輸送濃縮氧氣。 POC 通常使用電池電源、交流電或直流電，這使得它們能夠適應各種環境，包括旅行。

攜帶式製氧機主要透過脈衝劑量系統輸送氧氣，每次吸入時都會大量釋放氧氣，儘管有些型號也提供連續流量選項。航空公司越來越接受 POC 在飛行中使用，這進一步提高了其在旅行期間需要氧氣治療的用戶中的受歡迎程度。

市場動態：

驅動程式和限制

攜帶式製氧機的採用率不斷上升

攜帶式製氧機 (POC) 市場正在經歷顯著成長，這主要是由於這些設備的日益普及所推動的。促成這一趨勢的幾個關鍵因素包括技術的進步、患者人數的成長以及不斷變化的醫療保健動態。隨著全球人口老化，與年齡相關的呼吸系統問題也相應增加。老年人特別容易患慢性阻塞性肺病（COPD）和其他慢性肺部疾病，這些疾病通常需要長期氧氣治療。例如，美國疾病管制與預防中心表示，2021年，超過1500萬美國人（6.4%）報告他們被診斷出患有慢性阻塞性肺病。

老年患者更有可能需要氧氣治療，他們更喜歡攜帶式解決方案，使他們能夠維持日常活動和積極的生活方式。例如，根據美國國立衛生研究院2024年的數據，美國每年約有150萬名患者接受長期氧氣治療。這種人口結構的變化極大地增加了對 POC 的需求。許多需要長期氧氣治療的人更喜歡家用攜帶式濃縮器，而不是固定系統或氣瓶。 POC 允許用戶在家中保持移動性並促進戶外活動。

與早期型號相比，現代設備現在更小、更輕且更方便用戶使用。電池技術的創新增強了這些集中器的便攜性，從而延長了電池壽命並提高了使用過程中的舒適度，使它們對患者更具吸引力。

有限的氧氣流量

攜帶式製氧機（POC）市場正在穩步成長，主要是由於慢性阻塞性肺病（COPD）、氣喘等呼吸系統疾病的盛行率不斷上升以及人口老化。然而，由於許多設備提供的氧氣流量有限，市場面臨挑戰。

攜帶式製氧機通常提供 1 至 3 公升/分鐘 (LPM) 之間的氧氣流量以實現連續流動，對於脈衝流量設定可提供更高的流量。然而，患有更嚴重呼吸系統疾病的患者可能需要更高的流速，例如 5 LPM 或更高。這項限制限制了許多 POC 對患有晚期 COPD 或其他嚴重呼吸道疾病的個體的可用性，從而縮小了製造商的目標市場。因此，上述因素可能會阻礙市場的成長。

Portable Oxygen Concentrators (POCs) are compact, lightweight devices that provide supplemental oxygen to individuals with respiratory needs while away from home. These machines draw in ambient air, filter it, and deliver concentrated oxygen through a nasal cannula or mask. POCs typically utilize battery power, AC electricity, or DC power, making them versatile for various settings, including travel.

Portable oxygen concentrators deliver oxygen primarily through pulse dose systems, releasing oxygen in bursts with each inhalation, although some models also offer continuous flow options. The growing acceptance of POCs by airlines for in-flight use has further enhanced their popularity among users who require oxygen therapy during travel.

Market Dynamics: Drivers & Restraints

Rising adoption of portable oxygen concentrators

The portable oxygen concentrators (POCs) market is experiencing significant growth, largely driven by the increasing adoption of these devices. Several key factors contribute to this trend, including advancements in technology, a growing patient population, and evolving healthcare dynamics. As the global population ages, there is a corresponding rise in age-related respiratory issues. Older adults are particularly vulnerable to conditions like chronic obstructive pulmonary disease (COPD) and other chronic lung diseases, which often necessitate long-term oxygen therapy. For instance, the Centers for Disease Control and Prevention stated that in 2021, more than 15 million Americans (6.4%) reported that they had been diagnosed with COPD.

Elderly patients, who are more likely to require oxygen therapy, prefer portable solutions that enable them to maintain their daily activities and active lifestyles. For instance, according to the National Institute of Health in 2024, each year, approximately 1.5 million patients in the USA receive long-term oxygen therapy. This demographic shift significantly boosts the demand for POCs. Many individuals requiring long-term oxygen therapy favor portable concentrators for home use over stationary systems or cylinders. POCs allow users to maintain mobility within their homes and facilitate outdoor activities.

Modern devices are now smaller, lighter, and more user-friendly compared to earlier models. Innovations in battery technology have enhanced the portability of these concentrators, resulting in longer battery life and improved comfort during use, making them more appealing to patients.

Limited oxygen flowrates

The portable oxygen concentrators (POCs) market is experiencing steady growth, primarily driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and the aging population. However, the market faces challenges due to the limited oxygen flow rates offered by many devices.

Portable oxygen concentrators generally provide oxygen flow rates between 1 to 3 liters per minute (LPM) for continuous flow, with higher rates available for pulse flow settings. However, patients with more severe respiratory conditions may require higher flow rates, such as 5 LPM or more. This limitation restricts the usability of many POCs for individuals with advanced-stage COPD or other serious respiratory diseases, thereby narrowing the target market for manufacturers. Thus, the above factors could hinder the market growth.

Segment Analysis

The global Portable Oxygen Concentrators market is segmented based on product type, application, end-user and region.

Product Type:

Continuous flow oxygen concentrators segment is expected to dominate the portable oxygen concentrators market share

The continuous flow oxygen concentrators segment is expected to dominate the portable oxygen concentrators market. Continuous flow concentrators are particularly advantageous for patients with severe respiratory conditions, as they provide a steady supply of oxygen without the need for breath detection technology, making them more reliable for those requiring higher flow rates.

Additionally, advancements in technology have improved the efficiency and reliability of these devices, enhancing their appeal in both home healthcare settings and medical facilities. The cost-effectiveness of continuous flow concentrators, which tend to be cheaper than pulse flow models due to their simpler design, also contributes to their growing market dominance. For instance, the range of continuous flow portable oxygen concentrators begins from Philips SimplyGo, costing around ₹ 1.80 Lakh, to the top-end SeQual Eclipse, costing around ₹ 3.20 Lakh. This makes the consumers feel convenient over the other types.

Geographical Analysis

North America is expected to hold a significant position in the portable oxygen concentrators market share

North America holds a major portion of the portable oxygen concentrators market and is expected to hold a significant position in the portable oxygen concentrators market. This is due to the growing adoption of portable oxygen concentrators, the increasing number of product launches, and the rising prevalence of respiratory diseases.

The region is experiencing high rates of respiratory diseases such as asthma and COPD among others which increases the need for oxygen therapy. Increasing these conditions in the region increases the demand for these devices. For instance, according to the Asthma and Allergy Foundation of America, nearly 28 million people in the U.S. have asthma. This equals about 1 in 12 people. Nearly 23 million U.S. adults ages 18 and older have asthma. Asthma rates are highest in Black adults in the U.S.

The presence of a large number of key players in the region is also contributing to the growth of the region's market. Companies are introducing the latest portable oxygen concentrators in the region. For instance, in October 2024, Inogen, Inc. announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. With an additional, fourth flow setting delivering up to 840ml/min of medical grade oxygen, in a lightweight user-friendly design of less than 3 lbs1 and three battery configurations providing up to 5 hours and 45 minutes of operation2, the versatility of Rove 4 empowers patients with choices that may help them with normal activities of daily living.

Thus, rising technological advancements, increasing adoption and rising number of launches of the products in the region are expected to drive the region's market growth.

Asia-Pacific is growing at the fastest growing pace in the portable oxygen concentrators market

Asia-Pacific is at the fastest growing pace in portable oxygen concentrators. This is due to the rising number of launches of advanced oxygen concentrators and rising technological advancements in the region. There is a growing number of respiratory diseases among individuals in the region who are receiving oxygen therapies which is raising the demand for portable oxygen concentrators which makes the individuals carry them easily.

There is a growing adoption of portable oxygen concentrators among individuals in the region. With the rising number of Asthma patients, the need for these devices is rising. For instance, according to the report by the Global Asthma Network in 2022, among India's 1.36 billion people, about 35 million suffer from asthma.

Competitive Landscape

The major global players in the portable oxygen concentrators market include Inogen, Inc., Koninklijke Philips N.V., Pure O2 Ltd, Belluscura, BPL Medical Technologies, GCE Group, Timago, CAIRE Inc., ResMed, and Invacare Corporation among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global portable oxygen concentrators market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising adoption of portable oxygen concentrators
- 4.1.2. Restraints
  - 4.1.2.1. Limited oxygen flowrates
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Continuous Flow*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Pulse Dose

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Asthma*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. COPD
7.4. Respiratory Distress Syndrome
7.5. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Homecare*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Travelers
8.4. Hospitals
8.5. Ambulatory Surgical Centers
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Inogen, Inc.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Koninklijke Philips N.V.
11.3. Pure O2 Ltd
11.4. Belluscura
11.5. BPL Medical Technologies
11.6. GCE Group
11.7. Timago
11.8. CAIRE Inc.
11.9. ResMed
11.10. Invacare Corporation

LIST NOT EXHAUSTIVE